Advanced Pathophysiology & Pharmacology with Detailed
Rationales | 100% Verified | Pass Guaranteed – A+ Graded
Section A: Pharmacokinetics — Absorption, Distribution, Metabolism,
Excretion (ADME)
Q1: A 68-year-old patient with liver cirrhosis is prescribed propranolol 40 mg PO twice
daily for portal hypertension. The nurse educator knows that this patient's first-pass
metabolism will be significantly altered. Which route of administration would BEST
bypass hepatic first-pass metabolism while still delivering systemic effects?
A. Oral administration with a high-fat meal to enhance absorption
B. Intravenous bolus injection to achieve immediate peak concentration
C. Sublingual administration to allow direct absorption into systemic circulation
D. Rectal suppository placed in the upper rectum for portal venous drainage
Correct Answer: C
Rationale: Sublingual administration allows drugs to diffuse directly into the systemic
circulation via the sublingual veins, completely bypassing hepatic first-pass
metabolism. Intravenous administration also bypasses first-pass metabolism but the
question asks for the best alternative route that avoids the liver while still being
practical; sublingual is the classic teaching example. Oral administration always
subjects drugs to first-pass metabolism, and upper rectal administration drains into the
portal system, exposing drugs to hepatic metabolism.
,Q2: A nurse educator is teaching students about factors affecting drug absorption. A
patient taking tetracycline for a skin infection reports taking it with milk and an antacid.
The educator explains that absorption is significantly reduced due to:
A. Increased gastric pH enhancing drug ionization and trapping
B. Chelation with calcium, magnesium, and aluminum forming insoluble complexes
C. Accelerated gastric emptying reducing contact time with absorption surfaces
D. Increased splanchnic blood flow shunting drug past intestinal mucosa
Correct Answer: B
Rationale: Tetracycline forms insoluble chelation complexes with divalent and trivalent
cations (Ca²⁺, Mg²⁺, Al³⁺, Fe²⁺) found in milk, dairy products, and antacids, rendering the
drug unabsorbable. This is a classic pharmacokinetic interaction. While increased
gastric pH can affect absorption of some drugs, tetracycline's primary issue with
milk/antacids is chelation, not pH alteration or gastric emptying changes.
Q3: A 45-year-old patient with hypoalbuminemia (albumin 2.1 g/dL) is prescribed
warfarin 5 mg daily. The nurse educator anticipates which pharmacokinetic alteration?
A. Decreased free fraction of warfarin leading to subtherapeutic INR
B. Increased free fraction of warfarin increasing bleeding risk
C. Decreased volume of distribution requiring higher loading doses
D. Increased protein binding enhancing drug storage in adipose tissue
Correct Answer: B
,Rationale: Warfarin is highly protein-bound (approximately 99%). In hypoalbuminemia,
fewer binding sites are available, increasing the free (unbound) fraction of the drug.
Since only free drug is pharmacologically active, this increases the risk of bleeding even
with standard doses. The volume of distribution for highly protein-bound drugs may
actually increase with hypoalbuminemia, not decrease.
Q4: A nurse educator is reviewing the cytochrome P450 system with graduate nursing
students. A patient taking rifampin for tuberculosis develops reduced efficacy of their
oral contraceptive. The educator explains this interaction occurs because rifampin is a:
A. Competitive inhibitor of CYP3A4, reducing estrogen metabolism
B. Non-competitive inhibitor of CYP2D6, increasing progestin levels
C. Potent inducer of CYP3A4, accelerating estrogen and progestin metabolism
D. Substrate for CYP2C19, displacing contraceptive hormones from binding sites
Correct Answer: C
Rationale: Rifampin is a potent broad-spectrum inducer of multiple CYP450 enzymes,
particularly CYP3A4. Oral contraceptives containing ethinyl estradiol and progestins are
primarily metabolized by CYP3A4. Enzyme induction increases the metabolic clearance
of these hormones, reducing their contraceptive efficacy. This is a classic
pharmacokinetic drug-drug interaction requiring alternative contraception during
rifampin therapy.
Q5: A patient with chronic kidney disease (eGFR 25 mL/min) is prescribed gentamicin
for a gram-negative infection. The nurse educator emphasizes that dosing adjustments
are necessary primarily due to altered:
, A. Hepatic Phase II conjugation reducing drug inactivation
B. Glomerular filtration and tubular secretion of the aminoglycoside
C. Enterohepatic recirculation increasing drug half-life
D. Plasma protein binding increasing free drug concentration
Correct Answer: B
Rationale: Gentamicin is an aminoglycoside antibiotic eliminated almost entirely by the
kidneys via glomerular filtration with minimal tubular secretion or reabsorption. In CKD,
reduced GFR significantly prolongs the half-life of gentamicin, increasing the risk of
nephrotoxicity and ototoxicity. Dosing must be adjusted based on renal function and
therapeutic drug monitoring is essential.
Q6: A nurse educator is teaching about the concept of steady-state concentration (Css).
A patient begins taking phenytoin 300 mg daily for seizure prophylaxis. The educator
correctly states that steady-state concentration will be achieved after approximately:
A. One half-life of the drug
B. Three half-lives of the drug
C. Five half-lives of the drug
D. Ten half-lives of the drug
Correct Answer: C
Rationale: Steady-state concentration is achieved after approximately 4-5 half-lives of a
drug, when the rate of drug administration equals the rate of elimination. Phenytoin has